Electromed (ELMD) EBT Growth (1y) (2011 - 2026)
Electromed (ELMD) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 74.66% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -27.02% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 54.33% |
| 10 | Electromed | 306.48 Mn | 289.50 Mn | 14.64 Mn | 69.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.41% |
| Dec 31, 2025 | 38.42% |
| Sep 30, 2025 | 31.46% |
| Jun 30, 2025 | 27.15% |
| Mar 31, 2025 | 16.37% |
| Dec 31, 2024 | 14.20% |
| Sep 30, 2024 | 873.97% |
| Jun 30, 2024 | 62.67% |
| Mar 31, 2024 | 60.47% |
| Dec 31, 2023 | 84.15% |
| Sep 30, 2023 | 356.25% |
| Jun 30, 2023 | 207.62% |
| Mar 31, 2023 | 40.62% |
| Dec 31, 2022 | 18.39% |
| Sep 30, 2022 | -91.22% |
| Jun 30, 2022 | -23.23% |
| Mar 31, 2022 | 243.48% |
| Dec 31, 2021 | -32.08% |
| Sep 30, 2021 | -18.60% |
| Jun 30, 2021 | -49.97% |